Teladoc (TDOC) stock closed down 0.84%, underperforming sector and S&P 500.

From Nasdaq: 2024-12-27 18:15:21

Teladoc (TDOC) closed at $9.45, down 0.84% from the previous day, narrower than the S&P 500’s 1.11% loss. The stock has fallen by 16.62% in the past month, underperforming the Medical sector and the S&P 500. Analysts expect earnings of -$0.20 per share and revenue of $638.31 million in the upcoming report.

Investors await Teladoc’s earnings report, expecting a year-over-year decline of 17.65% in earnings. The Zacks Consensus Estimates project earnings of -$5.80 per share and revenue of $2.57 billion for the annual period. Analysts’ revisions to forecasts can impact stock prices, with Teladoc currently holding a Zacks Rank of #3 (Hold).

The Medical Services industry, part of the Medical sector, ranks 79 out of 250+ industries. Industries with higher Zacks Industry Rank tend to outperform others. Stay informed about stock-shifting metrics by utilizing Zacks.com. Additionally, Zacks is naming the top 10 stocks for 2025, with a history of significant performance.

Zacks Top 10 Stocks gained over 2,100% from 2012-2024, surpassing the S&P 500. The Director of Research is selecting 10 tickers for 2025, set to be released on January 2. Early access to these top picks could lead to substantial gains. Stay ahead of the market with Zacks Investment Research for the latest recommendations.



Read more at Nasdaq: Teladoc (TDOC) Stock Moves -0.84%: What You Should Know